HARPER SUTTON: Open Payments
NPI 1790509602 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 33 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $269 |
| AstraZeneca Pharmaceuticals LP | 4 | $165 |
| PFIZER INC. | 5 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Astellas Pharma US Inc | 1 | $32 |
| Exact Sciences Corporation | 2 | $32 |
| Dexcom, Inc. | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Almatica Pharma LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: AIRSUPRA, Rybelsus, Ozempic, NURTEC ODT, CAPLYTA, Veozah, PREVNAR 20, Dexcom G6 Transmitter.
Industry payments across TN — which companies pay providers there.
